Key takeaways
- Google prohibits promoting unapproved pharmaceuticals and supplements “regardless of any claims of legality”, and names products implying equivalence to prescription drugs and products subject to regulatory action or warning.
- Meta prohibits ads promoting “illicit or recreational drugs, or other unsafe substances, products or supplements, as determined by Meta at its sole discretion”, and lists human growth hormones among unsafe supplements.
- “Sole discretion” is the operative phrase across every platform. There is no list you can satisfy and no wording that converts a prohibited category into an allowed one.
- Repeatedly resubmitting rejected ads, or running new accounts after a disable, tends to escalate rather than resolve — platform enforcement travels across accounts, domains, payment methods and people.
- The channels that remain are the ones this category is actually good at: verifiable documentation, organic search, email to consenting customers, and commission-only affiliates.
- Plan the acquisition model around this from the start. A store whose unit economics assume paid social is a store built on a channel it cannot access.
What the policies say
This question gets answered in forums far more often than it gets answered from the policies, so start with the policies. They are public, short and unusually direct.
Google’s policy on unapproved pharmaceuticals and supplements opens by stating that “Google doesn’t allow the promotion of certain products, regardless of any claims of legality.” The prohibited set includes a non-exhaustive list of unapproved pharmaceuticals and supplements, herbal and dietary supplements with active pharmaceutical or dangerous ingredients, products implying equivalence to prescription drugs or controlled substances, products marketed as safe or effective for treating diseases without government approval, products subject to government or regulatory action or warning, and products with names confusingly similar to unapproved pharmaceuticals.
Meta’s advertising standards prohibit ads that “promote the sale or use of illicit or recreational drugs, or other unsafe substances, products or supplements, as determined by Meta at its sole discretion.” Its unsafe-substances standard names anabolic steroids and human growth hormones among unsafe supplements. Prescription drug advertising is permitted only for advertisers who evidence appropriate licensing.
TikTok, Microsoft, Snap and the rest publish comparable healthcare and pharmaceutical restrictions through their own policy hubs. The specifics differ; the shape does not.
| Platform | Published position | Practical effect |
|---|---|---|
| Google Ads | Prohibits promotion of unapproved pharmaceuticals and supplements “regardless of any claims of legality”, including products subject to regulatory action or warning | Research peptide catalogs generally fall inside the prohibited set; the disclaimer on your site does not change the ad policy |
| Meta | Prohibits ads promoting unsafe substances, products or supplements “as determined by Meta at its sole discretion”; names human growth hormones among unsafe supplements | Approvals are revocable and inconsistent; an ad that ran last month is not precedent |
| TikTok | Publishes healthcare, pharmaceutical and weight-management restrictions through its policy hub | Check the current article before assuming; the category sits inside restricted or prohibited industries |
| All of them | Enforcement is at the platform’s discretion, applied across accounts, domains and payment methods | Workarounds compound the problem rather than solving it |
Why appeals and rewording rarely change the outcome
The most common merchant response to a rejection is to reword the ad. It occasionally clears a specific creative, and it does not address the reason, because the objection is usually to the landing page and the business rather than to the sentence in the ad.
Google’s wording is explicit that legality claims do not matter, and Meta’s reserves the decision to Meta. Neither is a standard you can document your way past. An appeal is worth making once where you genuinely believe the category was misidentified; a cycle of resubmissions is not.
The escalation risk is real and under-appreciated. Repeated policy violations, new accounts created after a disable, and attempts to route around a block are themselves enforceable conduct on every major platform, and enforcement associates accounts with domains, payment instruments, business managers and people. A store that plays that game usually ends up unable to advertise anything, ever, including things that were never restricted.
There is also a compliance dimension that has nothing to do with the ad platform. Advertising copy is part of the evidence of intended use — outcome language in an ad is the same evidence as outcome language on a product page. Writing a claim into an ad to make it perform is the single fastest way to create the problem described in is it legal to sell research peptides.
What actually works instead
The constraint is real, and it is also survivable, because the channels that remain suit this category better than paid social ever did. They are slower and they compound, which changes how a business should be planned rather than whether it can exist.
Verifiable documentation is the strongest asset available. Lot-matched certificates a buyer can check before purchasing are the thing this category’s customers actually evaluate, and almost nobody does it well. Publishing it properly is both a trust asset and the substance that organic search rewards.
Organic search and AI answers are the second. Buyers and founders in this category research heavily, and the questions they ask have poor answers available — which is an unusual amount of room for a store willing to write accurate, sourced material. Email to consenting customers is the third, and the cheapest revenue per dollar in the business. Commission-only affiliates are the fourth, and cost nothing until they produce a sale.
None of those needs an ad account, and none of them can be switched off by a policy review. See affiliate programs for a research supply brand, abandoned checkout and receipt emails and helpful content for AI search.
- Publish lot-matched documentation reachable without an account.
- Answer the questions your buyers and peers actually search, accurately and with sources.
- Build the consenting email list from day one; it is the only channel you own.
- Run a commission-only affiliate programme rather than paying for posts.
- Keep every channel free of outcome language, because ad copy is evidence too.
Planning a store that does not need ads
The practical consequence is a different financial model. A business that cannot buy traffic has to convert the traffic it earns, which puts the weight on the storefront, the documentation and the repeat rate rather than on acquisition spend.
That argues for a short catalog done thoroughly, a product page that answers buying questions without persuasion, documentation that is genuinely checkable, and operational reliability that produces repeat orders. It also argues for patience: organic and reputation compound over months, not weeks, and a plan that needs revenue in week three is a plan that will reach for a prohibited channel.
Torva OS is built for that shape of business — certificates per product and lot, a claim reviewer that keeps outcome language out of product copy, email automations and affiliates on the same workspace, so the channels that are available are the ones the platform is good at. You can preview a store free, with no card, and the cost guide covers how the absence of paid acquisition changes the budget.
Frequently asked questions
Can you run Google Ads for peptides?
Google’s policy prohibits promoting unapproved pharmaceuticals and supplements “regardless of any claims of legality”, and expressly includes products subject to government or regulatory action or warning and products implying equivalence to prescription drugs. Research peptide catalogs generally fall inside that set.
Can you advertise peptides on Facebook, Instagram or Meta?
Meta prohibits ads promoting unsafe substances, products or supplements “as determined by Meta at its sole discretion”, and names human growth hormones among unsafe supplements. Because the standard is discretionary, an ad that ran previously is not evidence that the category is permitted.
What happens if I keep resubmitting rejected ads?
Repeated policy violations and attempts to route around a block are themselves enforceable on every major platform, and enforcement associates accounts with domains, payment methods and people. The usual outcome is a broader and more permanent loss of access than the original rejection.
Are ads part of what a regulator looks at?
Advertising is one of the sources from which intended use is established. Outcome language in an ad is the same kind of evidence as outcome language on a product page, so the compliance reason to avoid it exists independently of the ad platform’s policy.
What can a research-supply store actually use?
Verifiable lot-matched documentation, organic search and AI answers, email to consenting customers, and commission-only affiliates. They are slower than paid social and they compound, and none of them can be withdrawn by a policy review.
Sources
Preview your store on Torva OS — no card needed — or explore the Desk demo, the eight themes and the plans. Questions: hello@torvaos.com.
General information for merchants, not legal, tax or financial advice. Check the rules in your jurisdiction and with your providers.